Contents | 4 of 30

The Use of Acetazolamide During Pregnancy in Intracranial Hypertension Patients

Update Item Information
Title Journal of Neuro-Ophthalmology, March 2013, Volume 33, Issue 1
Date 2013-03
Language eng
Format application/pdf
Type Text
Publication Type Journal Article
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
ARK ark:/87278/s6r81m9z
Setname ehsl_novel_jno
ID 227437
Reference URL https://collections.lib.utah.edu/ark:/87278/s6r81m9z

Page Metadata

Title The Use of Acetazolamide During Pregnancy in Intracranial Hypertension Patients
Creator Falardeau, Julie; Lobb, Brenna M; Golden, Sara; Maxfield, Steven D; Tanne, Emanuel
Affiliation Department of Ophthalmology; Intracranial Hypertension Registry; and Intracranial Hypertension Research Foundation, Oregon Health and Science University, Portland, Oregon; and Dartmouth Medical School, Hanover, New Hampshire
Abstract Acetazolamide is the mainstay of medical therapy for idiopathic intracranial hypertension (IIH). Its use in pregnant women has not been recommended because of reported teratogenic effects in rodents and rabbits. However, the safety of acetazolamide use during human pregnancy remains unclear. We report the pregnancy and offspring outcomes in women with intracranial hypertension (IH) treated with acetazolamide during pregnancy. Data were collected through questionnaires sent to patients with IH and their physicians. The questionnaires focused on IH diagnosis, obstetric history and outcomes, and pediatric outcomes. A total of 101 women with IH were consented (total of 158 pregnancies) and acetazolamide usage before 13 weeks of gestation was reported in 50 pregnancies. The risk of spontaneous abortion was similar to the control group and no major complication was identified in the offspring of women treated with acetazolamide. There is no convincing evidence for an adverse effect for acetazolamide use in human pr nancy, even when prescribed prior to the 13th week of gestation. While the liberal use of acetazolamide should be avoided during pregnancy, this medication should remain a treatment option in pregnant women when clinically indicated.
Subject Acetazolamide; Adult; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Pseudotumor Cerebri; Questionnaires; Treatment Outcome
OCR Text Show
Format application/pdf
Publication Type Journal Article
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
Setname ehsl_novel_jno
ID 227410
Reference URL https://collections.lib.utah.edu/ark:/87278/s6r81m9z/227410